“…A White House-backed advocacy group has fired one of its fundraisers and returned a $100,000 check she collected from a New Jersey doctor who is seeking a presidential pardon for Medicare fraud, officials of the group told NBC News.
Organizing for Action, or OFA, a political nonprofit set up last year to promote the president’s policies, confirmed that it dismissed consultant Samantha Maltzman this week after receiving inquiries from NBC News about a contribution she had brought in from Dr. Joseph Piacentile, who was convicted in 1991 for Medicare fraud and tax evasion.”…
Piacentile did not attend the dinner, removed from the guest list after OFA vetters flagged his felony conviction, according to the OFA official who spoke on condition of anonymity. His pardon application shows that he was sentenced in 1994 for Medicare fraud and tax evasion, serving six months in a halfway house and agreeing to a $900,000 consent judgment. He has since founded a whistleblowers group dedicated to exposing health care and other frauds…”
Greg Thorpe originally blew the whistle on GSK’s fraudulent activity- and it was as a direct result of Greg’s actions- that GSK were fined 3 Billion in 2012 by the department of Justice. Greg regularly leaves comments on this blog, and they are always extremely interesting, particularly in relation to the department of Justice- GSK fine -debacle.
I call this scandal a debacle because I have long thought that GSK’s fine of 3 billion, and the corporate integrity agreement etc, was merely a little slap on the wrist for GSK. People died because of GSK’s various unethical shenanigans; crimes committed by GSK over many years: many patients were harmed, maimed or killed. GSK should have had its license to trade revoked, instead the department of Justice fined them 3 months profits and allowed to them continue on -business as usual. The executives all sailed off into the sunset, dripping with even more wealth and money than they had previously earned – golden parachutes all-round for the GSK top brass-despite being party to the biggest health care fraud of the 21st century.
Astounding isn’t it?
I’ve always felt that the whole thing stank to high heaven, and furthermore, I have always wondered, why is Greg the only whistle-blower willing to tell the truth about this sham fine?
There were, apparently, another 5 whistle-blowers- why do they not speak out about the quid pro quo? Why do they not criticize Eric Holder and the revolving door? Why do they not speak out about this grave travesty of justice to consumers and patients? Why do they not speak about this slap on the wrist for GSK? Why do they not tell the public that far from being a success for patients, this fine was merely a sleight of hand and a smokescreen?- as GSK were allowed to continue on- as evident by their China-Bribe scandal in 214, to commit more bribery and fraud in different countries, further afield.
Why do they not inform the public about the real scandals of this debacle?
Thankfully, we have people like Greg, he’s not afraid to speak out- here is his latest comment-
There are hundreds if not thousands in the DOJ that are to say the least, are not interested in real justice or the truth. They are not in lockstep with Jeff Sessions to say the least. They regularly monitor this site. Truthman knows this. I hate to coin a phrase, but this swamp cannot be fully drained.
I have been threatened and put myself at risk with everything I say…they violated my constitutional rights by putting a gag order on me for 9 1/2 years…so GSK could continue to reap off label marketing profits and worst of all patients and physicians were kept in the dark. The law I filed under, the False Claims Act has no provision for this conduct, for such a length of time. They are allowed to seal the case only to investigate whether it has merit. I was interviewed under oath by the FBI…3 months after I filed. every government agency was present who had a stake in the case…DEA, HHS, FDA, DOD, IRS, CIA, VA ,DOJ, FBI and others…Shortly after that, I was informed through Counsel that DOJ had dozens of people on the case, and a entire floor at DOJ working on the case. I assume this was true. The False Claims Act seal is to only be extended after they decide to take the case, usually 6 months, for good cause. Obviously it became apparent after 9 years that the seal only remained in place so DOJ could secretly, without public knowledge cut a deal with GSK or go to trial. During this long, long period of time, I was never told that they had joined my complaint until the 11th hour AFTER the settlement was reached. They used this tactic to threaten me with non joining and tossing me out for 9 years plus. During this time, patients continued to receive prescriptions on the 9 drugs I reported …physicians were kept in the dark. In short, the carnage continued…I consistently objected but to no avail. The lead prosecutor told me after I demanded that this go to trial that they “would bankrupt the company, and nobody would get anything”…at the time I thought the statement may have merit, although I now know it was sheer B.S. It would be hard to bankrupt a company with a market cap approaching 200 billion dollars or more.. So I kept my mouth shut while people died, and that haunts me to this day. It included my mother who developed congestive heart failure while kept on Avandia, for diabetes. I did not know GSK had hidden data showing it caused CHF, until it was too late. Hundreds of thousands of patients suffered the same effect, and this was going on with all the drugs reported…but did the DOJ care. Hell no they kept all of this important data sealed from patients and physicians. Why ?
The only reason I know now was to negotiate a sweetheart deal for GSK under a former attorney for the company….ERIC HOLDER. Holder was supposed to have recused himself. I have no evidence that he did. I BELIEVE after he gave GSK the quid pro quo for his law firm, Covington Burling….IN A FINE THAT AMOUNTED TO 3 MONTHS OF COMPANY PROFIT..that he had his hand on the trigger. Supporting this is the fact that he returned to Covington Burling to what has been reported as a “hero’s welcome and a huge raise”.They were even nice enough to give him his old office back, supposedly saved for his return. Holder committed many acts as Attorney General which warrant investigation …but none of this caliber.
GSK lost 3 billion dollars…one month of profit. Nobody was prosecuted .
Nine and one half YEARS is a long time…especially to rob the taxpayers who fund these illegal prescriptions of 40-50 billion dollars, at least. This would not even be what the punishment calls for under the statute. People should be in prison and maybe the company should be bankrupt…they continued the crimes all over the world after the settlement, while under 3 corporate integrity agreements, which called for the so called “death penalty” meaning no Federal program Medicare, Medicaid, VA, etc could use ANY GSK drug..
Why? It defies anything I can come up with except massive criminal fraud and corruption at the highest levels of government. This is a huge story, what I saw and heard over ten years makes me literally sick…yet Nobody seemingly will say anything…the other , second to file whistleblowers, were a joke…copied my complaint, took their money and hid . Mere accomplices to the crimes in my opinion.
Do I fear retaliation for what I say…hell yes I do, but someone has to speak up on this.
I am hopeful someone in the DOJ will come forward, everyone cannot be corrupt or cowardly and I hope we will see under a new administration, something done.
As to the post about Jeff Sessions.. the answer is I don’t know what he can or will do. All I know is my son was in second grade when this began , now he is about to graduate from college. This hasn’t been easy for my family or me and I’m not sure if the swamp can ever be drained. I know a lot more, but someone in the DOJ has inside information…I hope they come forward. The lead investigator, Sara Bloom …would be a good start.
“…Britain’s Serious Fraud Office has launched a formal criminal investigation into GlaxoSmithKline’s sales practices, piling further pressure on the drugmaker which is already being investigated by Chinese authorities and elsewhere amid allegations of bribery.
Britain’s biggest pharmaceutical company, run by Sir Andrew Witty, said it had been informed on Tuesday that the SFO had “opened a formal criminal investigation into the group’s commercial practices”.
“GSK is committed to operating its business to the highest ethical standards and will continue to cooperate fully with the SFO,” it added. A spokeswoman was unable to give further information. It is understood the SFO is looking at possible patterns across numerous global jurisdictions including China.
Under the 2010 Bribery Act, the SFO has powers to investigate and prosecute corruption at home or abroad. In some circumstances companies can be considered for immunity from prosecution if they can demonstrate they have been proactive and alerted SFO investigators to evidence of wrongdoing as soon as they found it…”
Following on from my post two days ago (about Erika Kelton-Whistle-Blower attorneys’- article on GSK CEO Andrew Witty in Forbes online), GSK whistleblower Greg Thorpe left some interesting comments on it. (see here)
I have long thought that GSK’s 3 Billion dollar fine gave merely the appearance of justice-to the media and the public- but didn’t really deliver it at all. The only ones that really benefited from this 3 Billion dollar fine were the many attorneys involved and GSK themselves. Patients did not get justice, many people were harmed and some died. There was no real justice for those harmed.
On the surface of it, it seems like a lot of money, and a big fine, but 3 Billion is nothing to GSK, it’s around 3 months profit, and in any case- the profits that they made -pushing the various drugs detailed in Greg’s complaint off label- over the decade that the case was (unethically) sealed-and the years previous (to when Greg raised the alarm) more than made up for the criminal behavior that GSK were fined for anyhow.
As Greg so perfectly put it- this fine was a ‘gift’ to GSK.
Disturbingly also, GSK were then fined 2 years later (500 million) in the biggest corporate bribery scandal in China. It seems that GSK broke its corporate integrity agreement (one of the main stipulations for GSK’s fine with the US department of Justice) literally less than 2 years after it signed it. Was GSK setting up this bribery network during the time it was signing this corporate integrity agreement with the US department of Justice? Who was overseeing the funding of GSK’s elaborate bribery scam? that’s something that journalists and the media should be researching to find out…
GSK are also under investigation by the serious fraud office in the UK.
Personally, I don’t think that GSK will be brought to justice in the UK, or the US, for any of this extremely unethical and immoral behavior. GSK operate above the law because they are a cash cow for the UK economy; they are hugely influential over politics, healthcare, universities, and the media- globally. They are an unimaginably profitable company, and their stranglehold upon powerful people, and organizations around the world (from political sway to university/academic control), stretching back about a century, keeps them protected from facing justice for any of the crimes that they commit.
GSK epitomize an evil, untouchable, unaccountable corporate entity that has influence and power beyond our imaginations. They get away with corporate fraud, bribery, harm to patients (and often corporate manslaughter of patients) because the governments and justice systems (particularly, in the UK, Europe and US) are nefariously influenced by GSK’s huge financial, legal and corporate power. They have every facet of society in their pocket…
Like big oil and the military industrial complex, the big banks etc, Big Pharma’s like GSK are literally untouchable. From time to time they face paltry, meaningless, fines, such as the department of Justice charade- however their corporate culture remains the same.
They hire people like Andrew Witty to become the face of their new branding strategy, but they never ever atone for many of the crimes that they commit.
At the end of the day, it’s all about money and greed…
In this corporate dominated world, the individual is considered value-less and disposable..
The average joe, on the street; the ordinary consumer or patient- has little or no power, to fight these kinds of corporations. If big oil destroys the environment, it doesn’t have to face any real justice, if the military industrial complex wants to fund wars in the middle east, leading to deaths of innocent people in those areas, maiming and dismembering kids and women, and men- it’s allowed to, and if Big Pharma wants to sell a dodgy drug to you, and lie about side effects, and even kill you and get away with it, it’s allowed to do this without proper recourse.
The CEO’s of these entities, are so rich, and well protected by the high political, legal and professional class, that they can simply do what they please, and at the end of their tenure, they can ride off into the sunset with multi-million pound nest eggs and golden parachutes. It doesn’t matter what the corporation does while the CEO is in charge, even if the company commits fraud continually, and pushes drugs off-label to people harming them and sometimes killing them- the CEO’s are let off the hook…
They are untouchable…
We are at their mercy, and they have no mercy..
They behave sociopathically because that’s the nature of how they do business. Despite protestations of new ethical branding, they are unable to change because the corporate environment in which they thrive doesn’t allow for humane characteristics.
If GSK think that I am wrong about anything that I have written on my blog, I am open to amending any blog post to set the record straight, and furthermore I would be happy to discuss any of the issues raised on this blog with Andrew Witty, the CEO, of GSK anytime and anyplace (as long as its recorded and released to the public) so there you go Andrew, take me up on that offer anytime you wish- and show the world that GSK are really concerned with ‘patients first’ and ‘transparency’ – prove to the world that you’re not the corporate lackey that we all think you are…
(I won’t hold my breath)
Anyhow, here’s Greg’s comments– make of them what you will…
Erika Kelton and her so called whistleblowers are frauds, period.
Kelton told me specifically in a letter that “Off label marketing is not fraud”.
Her firm would not take this case until they found out I was right.
Both her me too whistleblowers were terminated GSK employees and Matt Burke was terminated for off label promotion as a Regional Manager, forcing some 200 plus representatives under him to do the same.
This was AFTER I went to the highest ranking people in the company, complaining of off label fraud and kickbacks.
These clones of me used much of the same information I sent Kelton…only to file a separate case about 4 months AFTER I had to get some rookie counsel to represent me.
Her version of the story and their statements are not only false and misleading but probably defamatory to my position on the case. The Department of Justice gave ME standing as first to file and my attorneys handled the award.
The award was decreased to the minimum largely because her “me too” terminated clients were actually deemed ” planners and initiators ” of the Fraud.
This was a 9 year joke, and that is the time it took the DOJ to decimate my complaint and reduce it from some 350 pages with 750 exhibits to some 80 pages or so of a huge quid pro quo to GSK.
I have a lot more to say on this and it was largely Kelton and her boys inaction and lack of substance on the major drugs…Paxil, Imitrex, Zyban and Wellbutrin that the settlement was so paltry.
The settlement amounted to 3 months of PROFIT for GSK. It makes me sick, and Kelton declares victory ? I call bullshit.
Criminal actions no doubt occurred over these 9 years including an illegal seal from the public on the case….9 years !! Sara Bloom, Kelton’s buddy was lead investigator and seemingly spearheaded the Gift to GSK.
I have questions as to the role of Eric Holder also in this whole charade.
A GSK defense attorney became Attorney General 5 years into the case. He supposedly recused himself, but there are indications he had his moles in the DOJ putting the clamps on any criminal indictment…let alone the insanely low penalty. Hundreds of thousands of patients were killed or suffered…nothing done. A slap on the wrist. Holder is now back at the same law firm, DEFENDING GSK. Anyone smell the RAT ?
I have a lot more intimate knowledge about all of this…and have already been threatened for coming forward.
I was the ONLY whistle-blower who was wrongfully terminated for coming forward.
So Erika until you can stop lying and putting lipstick on this pig of a case…that cost the taxpayers Tens… if not hundreds of millions of dollars…
I suggest you keep your mouth shut and comply with my request to show how you really handled the information I first gave to you…when you would not file, and declared in writing that “OFF LABEL DETAILING IS NOT FRAUD”…. It certainly is, especially when people die because of statements made to physicians, even by your own so-called whistle blowers
To Forbes …..
If you want the truth about this whole incredible 9 year quid pro quo….I will give you the truth, and not in some self serving article put forth to generate business for a lawfirm.
The article makes me want to puke. You will get the whole truth from me, not just what some me-too attorney wants you to believe.
Truth man, why don’t you publish the letter to me from Kelton ? Says it all on her integrity and real role in the case on the “killer” off label promotion…not some innocuous promotion on Advair for mild asthma, which in most cases helped patients….which she lays claim to…..having nothing on Imitrex, Paxil, or Avandia.
The really harmful drugs. A useless pawn, and I have the evidence, including HOW she got into the case, and it was not because of the DOJ at all initially.
Get real Erica, you can’t hide the real truth on this Government Fraud forever. That is the bottom line.
The truth will come out, and not in a few paragraphs here…sooner or later.
One other note, Kelton insists that GSK listen to internal whistleblowers.
Certainly I agree…however this is coming from an attorney and a lawfirm who would not listen to the only internal whistle-blower in the 3 Billion dollar gift.
Maybe Erica should take a little of her own advice..instead of only listening to terminated employees, planners and initiators of the Fraud, then claiming THEY
were the leading whistleblowers.
They both secured good jobs outside the company and lived the good life for ten years….while I went through hell for reporting while employed, then was subject to wrongful termination after almost 25 years with the company.
Really Erika…you can fool some of the people some of the time..as the saying goes.
Matt Burke, your main bread and butter, as you know… would not even put his name on the complaint until I forced him to do so, or hit the road. Some hero ?
Come clean, seriously…it is about more than generating business for your firm through false and misleading statements. Bottom line you and your clients only got in the way in this case, especially in settlement discussions. The truth hurts, huh ? If I am wrong Burke can reply….but he will not.
He was grossly unjustly enriched and could be in prison, instead of living the good life off of my initial complaints.
Greg Thorpe regularly posts comments on articles on this blog, and his views are always honest. I applaud Greg for having the courage to be the first whistle-blower to speak out against GSK’s misdeeds back in the early 2000’s (see here), and I applaud him further for having the tenacity not to quit, particularly in the subsequent fight against opportunistic individuals, and the vultures that have encircled him, ever since he decided to put his life on the line 13 years ago. I know what it’s like to put your life on the line, to fight tooth and nail, and to self sacrifice everything for the greater good, and I also know what it takes to persevere even when the vultures, sociopaths, and psychos, are sniping at your heels.
It takes guts.
Greg is not afraid to speak the truth about GSK’s sham 3 Billion dollar fine (see here). He is not afraid to tell us that this fine was not justice at all but merely a quid pro quo sham- a gift to GSK. He’s not afraid to tell us what really happened behind the gloss of the media spin.
GSK’s 3 Billlion dollar fine was a white-wash. It will not deter them, or any other pharmaceutical company, from continuing to harm patients in the pursuit of profits. It was not a success for patient rights (as some have advertised it), it was a success for GSK, the industry (and the lawyers who feed off FCA claims). It was akin to a slap on the wrist for GSK and business as usual.
Greg is not afraid to speak out against the whole damn stinking debacle.
The FCA (false claims act) has turned into a farce, and a highly lucrative industry (made up mainly of opportunists- lawyers and former ‘whistle-blowers’), and one individual who seems to have amassed a fortune from this new industry is Dr Joe Piacentile.
Dr Joe has apparently made up to 17 million by filing multiple FCA complaints against multiple pharmaceutical companies over several years.
Surely this kind of thing needs to be stopped in its tracks? How is it even ethical, or legal, to do this?
Is it not blatant opportunism and profiteering? Surely this kind of behavior debases the entire idea of law and of justice itself?
Dr Joe is part of an organization called Whistle Blowers Against Fraud. This organization is effectively a profit making enterprise. I see nothing on the WAF website about the dead and damaged patients from all the dodgy drugs they have allegedly exposed.
All I see (on these whistle-blower fishing websites) are advertisements about the billions of dollars of fines they have apparently recouped from the pharmaceutical industry.
I just see more greed..
And a lot of self promotion..
Dr Joe even admits on his own website (the Piacentile Family foundation) that he learned the in’s and out’s of how these fraudulent activities occur by being originally involved himself in defrauding America’s medicaid system.
In the mid-1980s, Dr. Joe was a partner in a national durable medical equipment company. In charge of a sales force of 160 employees, Dr. Joe grew sales from $1 million to $20 million in a mere three years. However, this early success did not end well. Dr. Joe and his partners each pled guilty to one count of fraud for reportedly “falsifying Medicare forms.” This brush with the justice system opened Dr. Joe’s eyes to the real damages caused by fraud and gave him a front row seat in observing the inner workings of the justice system’s prosecution of such crimes.
I understand that there probably has to be some financial incentive to blow the whistle on these huge companies and their wrong-doings, but surely making an entire career out of it has to be unethical?
Dr Piancentile has been controversial for many years now, precisely because of the reasons I have just outlined.
As recently as 2014 Dr Joe made headline news on NBC America because of a 100,000 dollar donation to President Obama. Dr Joe, it seems, was also seeking a pardon for his history of medicaid fraud.
I guess the medicaid fraud wasn’t good advertising for his Whistleblowers Against Fraud (WAF) venture?
A recent judgment against Greg Thorpe, by Joe Piacentile, was denied.
In short, Dr Joe was attempting to seek over 800,000 dollars off Greg Thorpe despite already receiving multiple millions in payments from the other so called ‘whistle-blowers’ involved in the original GSK FCA complaint.
Greg stood his ground.
Here is the judgement, in Greg’s favor…
Greg Thorpe was the first (and in my opinion- the only genuinely authentic ex-GSK employee/ whistle blower) who choose to blow the whistle on GSK’s unethical shenanigans in the US, and he regularly comments on this blog.
Without Greg’s initial concerns I don’t think that GSK’s 3 Billion dollar fine would have happened.
He did- after all- provide the majority of the original evidence in the department of Justice complaint (see here).
Some of his more recent comments have been very thought provoking for reasons of which I will comment upon later.
Greg left the following comment on this post of mine-
Former Pharma Exec Heads To Trial On Kickback Allegations
“…I am sick and tired of TAF…so called Taxpayers Against Fraud saying what should be done in these cases. They are not partially funded by attorneys. I would say they are for the most part TOTALLY funded by attorneys and while Patrick Burns calls for tougher action !–!-
his “nonprofit “, which actually is quite profitable for the attorney group…coddling up to the Department of Justice, having high ranking Pharma investigators at DOJ speak in exotic, costly forums, including the Attorney General.
This group only exists to keep the cost of filing a qui tam FCA complaint as high as possible..they grab over 50 % of the award to some whistle-blowers . …while the government is allowed to put illegal 9 year seals on cases, while gutting the guidelines of FCA law.
So they all gladly contribute, have yearly extravaganza events at taxpayer expense, all over the planet.
It is a write off for them, and then each year they name some me too attorney, like Erika Kelton their “attorney of the year”..while at the same time, the “giant killer”and founder, John Phillips tells me when I first wanted them to take the GSK case in Feb 2002. “WE DO NOT BELIEVE OFF LABEL MARKETING IS FRAUD”.
Later, his firm, under Erika Kelton files essentially the same information I gave them, after I had to get inexperienced help to file the case…and they found out.
So two ex GSK employees are recruited to become whistlblowers instead of me.
…one Matt Burke, a Regional GSK manager, terminated for the very things I told the company about OFF LABEL MARKETING. So they threaten their way into the case as second to file, with a complaint mirroring the things I gave them 8 months before I filed in Jan. 2003.
Phillips and Kelton wrote me that ” OFF LABEL MARKETING IS NOT FRAUD”.
I have the letter for anyone to read, including Burns..who has talked tough, yet done absolutely nothing about it regarding
This is a true tax exempt monopoly, preying on Whistleblowers and letting the government get by with the pitiful settlements, and settling for an easy buck. All they have to do is march in lockstep with the fraud they know that occurs in the prosecution of all these Pharma companies, not just GSK.
This group of self appointed Kings of Qui Tam Whistleblowers is more corrupt or just as corrupt as big Pharma, hiding behind tax exempt status and handing out huge Quid pro quos to the Department of Justice. …only so they can make their huge money grab, while they essentially sit on their asses and let the gov’t conspire under seal for 9 years, as in my case.
In spite of the efforts of my excellent attorneys… Kenney, McCafferty firm with Tavy Deming and Emily Lambert, (by the way also TAF members, of necessity I believe, not choice) the government has set up a situation where again TAF gets its tax exempt status (bullshit), and in return does NOT dare rock the boat of the Ship of Fools at DOJ, who in fact make money for big Pharma…not reach any logical, reasonable settlements for the defrauded taxpayers under the FCA. Again just follow the money, all smoke and mirrors and in the end an Attorney who wrote me in part —
“OFF LABEL MARKETING IS NOT FRAUD”, Erika Kelton ,”Queen of Qui Tam Law”
is named Attorney of The Year by TAF.
So long story short, do something or quit talking out of both sides of your mouth Burns, and everyone else at TAF.
I know the truth, and you should be investigated. ..right along with the killers in big Pharma.
YOU ARE ENABLERS OF THE CONDUCT, NOTHING MORE. YOU ALLOW EXECUTIVES TO GET AWAY WITH MURDER, JUST SO YOU REAP YOUR MILLIONS OF THE TRUE WHISTLE-BLOWER’S AWARDS….ASAP…”
Greg’s other interesting comment, left recently, was in relation to this post-
One thought on “How Did GSK Market The Horrible Death Drug Seroxat To Unsuspecting Doctors?”
“…I have seen and witnessed first hand, worse marketing in the US…although the DOJ did not seem to interested in digging very deep with Paxil fraud.
Why, because they were protecting the executives, including the infamous JP Garnier, Bob Ingram, and others. This would include the criminal Witty, who had to know about Paxil. He was in the antidepressant marketing arm after the merger, the then “commoner”-Andrew Witty.
His transgressions and crimes were ignored by prosecutors…I believe so it would not interfere with his ungodly ” knighting”…He was there in the period after the merger, a main player in the Wellbutrin scams. Paxil and Wellbutrin were marketed in a way, so that business from one did not cannibalize the other one.
This was also another elaborate scheme, that I brought forward…in addition to my main concern, not only marketing both to children under 18….but for very young children also.
What can be said about a company that does this, with the knowledge hidden from physicians and patients ..resulting in unnecessary suicides-side effects (including horrible withdrawal symptoms),
and conning the gov’t and insurance companies into paying.
Now we see a couple minor players in the industry indicted and facing trial, for much less than the deadly “three amigos”, listed above. Smoke and mirrors, diversion from the worst of the worst.
So now all 3 living the good life on blood money, murder money or at the very least manslaughter.
It sickens me that I spent 12 years plus, shining some light on these cockroaches for nothing, not even a fine or any punishment worth a damn, end of story.
SIR Witty, can spin it all he wants. He along with all the others are truly pathological liars. If what I say is not true, the bastards have hundreds of GSK and other outside attorneys to sue me. I believe they spend more on attorneys to save themselves, rather than do any significant Research and Development…Judicial Watch, here in the US …has been informed of some of this, but has declined to investigate anything? Who paid them off ?
The inside information is in the bowels of the DOJ, if they have not destroyed evidence already. Why they did not go all the way back to the year 1996, when they could have on Paxil and Wellbutrin is no mystery to me..Filing in Jan 2003, they had every right to, but again the whole illegally sealed case stinks and I am holding my nose trying to put my life back together…
It was all a sick joke, and they all are above the law, “to big to prosecute”. Now as I predicted with the non-penalty here, they have gone global, with Witty at the helm.
Everything else gets older every day, but there is no Statute of Limitations on criminal acts…and Witty, Garnier, Ingram, Viebacher, Stout, Rajaratnum and their foot soldiers, who orchestrated all these scams resulting in morbidity and mortality
should still be investigated….and not by a Crook like Eric Holder, once a GSK defender always a GSK defender and highly paid…both in govt. and by his cronies at the revolving door law firm…Covington Burling, a den of sociopaths in its own right. Justice it seems will never happen, at least on earth.
Keep plugging Truthman, I admire your tenacity…seemingly everyone else has clocked out and left. GSK is still there however, and as bad as ever.”…
“….Mr. Witty explained that consumers may not be actively visiting their physician for a chronic problem like migraines, so when new drugs come along, they must find out about them through advertising….”
(Andrew Witty -then VP-General Manager of Marketing for GSK- speaking in the Advertising Age October 1997)
“...The new “breakthrough” Imitrex (sumatriptan) turned out to be a big disappointment. The pain magically disappeared for a time, but then the zigzag would return out of the blue a few hours later. It was almost worse than letting it happen to begin with. Other variations of Imitrex didn’t help much more…”
(Imitrex user in Salon.com article 2015).
According to Greg Thorpe’s Department of Justice Complaint which led to the 2012 fine of 3 billion dollars for GSK:
GSK maintained an elaborate illegal marketing regime for the prescription drugs included in today’s settlement, including, according to filed documents:
Paying physicians (who could be counted on to influence their peers) as much as $25,000 for being a GSK “advisory board” member;
Enrolling 49,000 physicians and health professionals to be part of its speakers bureau;
Identifying physicians in academia to pay to speak on behalf of one of the company’s drugs;
Creating the PowerPoint “slide kits” that physicians would use to deliver canned presentations;
Using an elaborate “FaxBack” system allowing drug marketing reps to suggest articles related to off-label uses. The physicians would order these -off-label promotional materials by calling a toll-free number, and thus not appear to be responding to an illegal marketing effort by the drug marketing representative;
Pushing Imitrex, an adult medicine for migraine, for mild headaches, as well as for use in children, despite the FDA’s rejection of GSK’s application for child use due to lack of efficacy;
Pushing Lamictal, a drug approved only for partial seizures, in adults for other diagnoses. In at least one case a patient died from a reaction that the company had evidence could occur;
Marketing Paxil, the antidepressant, to children under 18 when it had not been approved for youngsters, and despite GSK’s own clinical trails that had shown that the drug was ineffective for children and also heightened the risk of suicide or other self-harming behavior three-fold; and,
Marketing the antidepressant Wellbutrin as superior to other antidepressant alternatives due to increased sexual functioning and weight loss, pushing the drug as the “happy, horny, skinny drug,” to concisely encapsulate GSK’s off-label Wellbutrin marketing campaign.
If Andrew Witty was Glaxo’s VP-General Manager of Marketing in 1997, then what did he know about the various marketing scams, suppression of side effects etc- which went on in the company at that time?
I was prescribed Seroxat in 1998 and information (or misinformation) about side effects was likely contained in some kind of ‘educational’ promotion to doctors back then. How much was Witty aware about Seroxat prescribing to kids? or Seroxat side effects generally? how much input did he have in the promotion of these drugs?
And how much was he aware about Imitrex, or off label prescribing of Imitrex in kids? He seemed to be involved in Wellbutrin marketing also, and Wellbutrin was one of the drugs named in the complaint, alongside Imitrex, and Paxil of course.
According to the aforementioned AdAge article from 1997, Mr Witty, as VP general manager of marketing, was very much involved in all aspects of GSK’s marketing of its drugs at this time-
“…We started experimenting with DTC early and made a relationship with the rulemakers,” says Mr. Witty.
Indeed, Glaxo has been the top advertiser in DTC prescription drug advertising-a business expected to hit $1 billion this year-for two years running. Last year alone, Glaxo’s nasal spray Flonase received $32.7 million in support, migraine remedy Imitrex got $20.4 million, Serevent asthma inhaler had $16.4 million.
Mr. Witty also is adding more product firepower this year with Glaxo’s new anti-smoking pill Zyban getting an estimated $55 million in support (the brand is even getting TV teaser ads prior to its launch)….”
We know now that Seroxat/Paxil was extremely dangerous for under-18’s (causing kids to kill themselves, self harm etc).
The RIAT study proved that beyond doubt.
We also know that GSK’s Zyban also proved to be dangerous also, resulting in suicidal and neuro-toxic side effects similar to the one Seroxat/Paxil induces (see my recent post on Zyban here)
And what do we know about Imitrex (sumatriptan)? The drug which Witty mentions in the 1997 article above?
Well, we know it was illegally pushed off label to kids and according to a recent comment to me by GSK Whistle-blower Greg Thorpe, in regards to Imitrex he said (in a very brief synopsis):
“….Selling to kids , very young as migraines tend to run in families. They told us for years, the indication for kids was weeks away, seriously so everyone pushed it… also we paid off hundreds of physicians to promote it with lectures…not only for kids…but sinus headaches, tension headaches, menstrual migraine etcAll off label ..and yes it was a dangerous drug. ..a Vasoconstrictor one that not only worked on cranial blood blow, but also cardiovascular blood flow. Not for kids, and despite years of studies it was never proven safe or effective in kids under 18.In spite of that at least 25% was underage and another 25% off label.More money was spent making hundreds of docs, literally millionaires, speaking to groups about off label use.I can name many of them and did…”
-The lead investigator, Sarah Bloom, at the end of the 9 year saga, told Greg…that “she was unaware that Imitrex never was proven safe or effective in children”..
“….Although, I did not directly sell Paxil, I witnessed everything the Paxil reps said and did. I believe with what I knew and looking in the right places, a fine of much greater than 3 billion should have been paid for Paxil alone, and at least the same for Imitrex.GSK sold 3 billion dollars of Paxil the year I filed, 2003..most off label, and denying addictive properties.Obviously the DOJ was in coverup mode. Who was the ringleader, Sarah Bloom ?I highly doubt it. I also highly doubt they will do anything serious in other countries, after seeing what was done here”….
OFF-LABEL USE OF MIGRAINE DRUG GIVES CHILDREN RELIEF, STUDY SAYS
COLUMBUS, Ohio – A new study suggests that when over-the-counter medications fail to help children who suffer from chronic migraine headaches, those children may find relief with a drug traditionally prescribed to adults.
Around one out of every 10 children experience chronic migraines, said Ann Pakalnis, a study co-author and a clinical associate professor of pediatrics and neurology at Ohio State University and Columbus Children’s Hospital.
She and her colleagues treated 57 children with sumatriptan (Imitrex) nasal spray. More than three-quarters of the families in the study reported good to excellent relief of their child’s headaches after using the spray, and nearly 100 percent of the children in these families continued using the drug.
But sumatriptan isn’t approved by the U.S. Food and Drug Administration for use in children. The participants in this study were prescribed sumatriptan on an off-label basis, a common practice in which a medication is used to treat a group of people or a problem it wasn’t originally intended to treat.
“A nasal spray is the preferred way to deliver sumatriptan to children as their migraines tend to be very short, and the spray starts working in about 15 minutes.”
“By the time children see us at the headache clinic, they’ve already tried over-the-counter medications or milder prescription drugs,” said Pakalnis. “Their parents want a more aggressive treatment. They understand that it’s probably the best thing to do for their child, even if means an off-label use.”
The findings appear in a recent issue of the Journal of Child Neurology. Pakalnis conducted the study with Donna Kring, a nurse at Columbus Children’s Hospital, and Juliann Paolicchi, a pediatrician at the hospital.
The researchers took a retrospective approach to appraising sumatriptan’s effectiveness in children. They reviewed the medical charts of children 5 to 12 years old who were patients at Columbus Children’s Hospital, tallying the number of children prescribed the nasal spray. Each child’s family then received a questionnaire asking about the child’s use of the spray, its effectiveness and any concerns regarding the off-label use of the drug.
The majority (77 percent) of the 57 families who responded to the questionnaire reported that sumatriptan nasal spray had significantly helped their child, and 93 percent of these families noted that their child still used the drug.
Thirteen patients (23 percent) reported side effects from using the spray. Each of these children said the spray tasted bad, and five in this group stopped using it altogether. Sumatriptan nasal spray tastes very bitter and metallic to some children, Pakalnis said. Four of the 13 patients complained of dizziness. Two children found the spray difficult to use, and stopped using it.
“A nasal spray is the preferred way to deliver sumatriptan to children as their migraines tend to be very short, and the spray starts working in about 15 minutes,” Pakalnis said. “Some kids have a lot of nausea and vomiting with their headaches, which rules out giving them a tablet. Injection is another choice, but not a great option for children.”
Migraine triggers such as dehydration, fatigue and hormonal changes cause changes in nerve impulses that in turn affect blood vessel diameter and biochemical release. Blood vessel dilation causes pain, which analgesics can help alleviate. But analgesics don’t address the symptoms that often accompany migraines, such as nausea, vomiting and sensitivity to light and sound, which are usually caused by blood vessel constriction.
Sumatriptan and related drugs stop pain by restoring the nervous system’s ability to block pain impulses and help constrict blood vessels. And the triptans also help dilate the constricted vessels that contribute to they symptoms that accompany migraine attacks.
About 30 percent of the patients coming to Pakalnis’ office seek help for migraines. She and her colleagues currently prescribe sumatriptan nasal spray to about three-quarters of these patients.
“It’s an effective and safe treatment for children who don’t respond to over-the-counter pain killers,” she said.
The study was supported in part by Glaxo Smith Kline, makers of sumatriptan nasal spray.
You’d have to wonder, would Andrew Witty have allowed any of his kids to take drugs like Imitrex, or Seroxat, or Avandia, or Pandemrix?
I very much doubt it…
Because he would have known their full side effect profiles perhaps wouldn’t he?..
Or he would have at least been aware of the rumors about their dangers within the company…
How many kids and adults were misinformed and harmed?
See document (directly) below (from Greg Thorpe’s complaint) for an example of how GSK pushed Imitrex off-label.
(sumatriptan succinate) Injection
Read this Patient Information before you start taking IMITREX and each time you get a refill. There may be new information. This information does not take the place of talking with your healthcare provider about your medical condition or treatment.
What is the most important information I should know about IMITREX?
IMITREX can cause serious side effects, including:
Heart attack and other heart problems. Heart problems may lead to death.
Stop taking IMITREX and get emergency medical help right away if you have any of the following symptoms of a heart attack:
- discomfort in the center of your chest that lasts for more than a few minutes, or that goes away and comes back
- severe tightness, pain, pressure, or heaviness in your chest, throat, neck, or jaw
- pain or discomfort in your arms, back, neck, jaw, or stomach
- shortness of breath with or without chest discomfort
- breaking out in a cold sweat
- nausea or vomiting
- feeling lightheaded
IMITREX is not for people with risk factors for heart disease unless a heart exam is done and shows no problem. You have a higher risk for heart disease if you:
- have high blood pressure
- have high cholesterol levels
- are overweight
- have diabetes
- have a family history of heart disease
What is IMITREX?
IMITREX Injection is a prescription medicine used to treat acute migraine headaches with or without aura and acute cluster headaches in adults who have been diagnosed with migraine or cluster headaches.
IMITREX is not used to prevent or decrease the number of migraine or cluster headaches you have.
It is not known if IMITREX is safe and effective in children under 18 years of age.
Who should not take IMITREX?
Do not take IMITREX if you have:
- heart problems or a history of heart problems
- narrowing of blood vessels to your legs, arms, stomach, or kidneys (peripheral vascular disease)
- uncontrolled high blood pressure
- severe liver problems
- hemiplegic migraines or basilar migraines. If you are not sure if you have these types of migraines, ask your healthcare provider.
- had a stroke, transient ischemic attacks (TIAs), or problems with your blood circulation
- taken any of the following medicines in the last 24 hours:
- almotriptan (AXERT®)
- eletriptan (RELPAX®)
- frovatriptan (FROVA®)
- naratriptan (AMERGE®)
- rizatriptan (MAXALT®, MAXALT-MLT®)
- sumatriptan and naproxen (TREXIMET®)
- ergotamines (CAFERGOT®, ERGOMAR®, MIGERGOT®)
- dihydroergotamine (D.H.E. 45®, MIGRANAL®)
Ask your healthcare provider if you are not sure if your medicine is listed above.
- an allergy to sumatriptan or any of the ingredients in IMITREX. See the end of this leaflet for a complete list of ingredients in IMITREX.
What should I tell my healthcare provider before taking IMITREX?
Before you take IMITREX, tell your healthcare provider about all of your medical conditions, including if you:
- have high blood pressure
- have high cholesterol
- have diabetes
- are overweight
- have heart problems or family history of heart problems or stroke
- have kidney problems
- have liver problems
- have had epilepsy or seizures
- are not using effective birth control
- become pregnant while taking IMITREX
- are breastfeeding or plan to breastfeed. IMITREX passes into your breast milk and may harm your baby. Talk with your healthcare provider about the best way to feed your baby if you take IMITREX.
Tell your healthcare provider about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements.
IMITREX and certain other medicines can affect each other, causing serious side effects.
Especially tell your healthcare provider if you take anti-depressant medicines called:
- selective serotonin reuptake inhibitors (SSRIs)
- serotonin norepinephrine reuptake inhibitors (SNRIs)
- tricyclic antidepressants (TCAs)
- monoamine oxidase inhibitors (MAOIs)
Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure.
Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.
How should I take IMITREX?
- Certain people should take their first dose of IMITREX in their healthcare provider’s office or in another medical setting. Ask your healthcare provider if you should take your first dose in a medical setting.
- Use IMITREX exactly as your healthcare provider tells you to use it.
- Your healthcare provider may change your dose. Do not change your dose without first talking with your healthcare provider.
- For adults, the usual dose is a single injection given just below the skin.
- You should give an injection as soon as the symptoms of your headache start, but it may be given at any time during a migraine or cluster headache attack.
- If you did not get any relief after the first injection, do not give a second injection without first talking with your healthcare provider.
- If your headache comes back or you only get some relief after your first injection, you can take a second injection 1 hour after the first injection, but not sooner.
- Do not take more than 12 mg in a 24-hour period.
- If you use too much IMITREX, call your healthcare provider or go to the nearest hospital emergency room right away.
- You should write down when you have headaches and when you take IMITREX so you can talk with your healthcare provider about how IMITREX is working for you.
What should I avoid while taking IMITREX?
IMITREX can cause dizziness, weakness, or drowsiness. If you have these symptoms, do not drive a car, use machinery, or do anything where you need to be alert.
What are the possible side effects of IMITREX?
IMITREX may cause serious side effects. See “What is the most important information I should know about IMITREX?”
These serious side effects include:
- changes in color or sensation in your fingers and toes (Raynaud’s syndrome)
- stomach and intestinal problems (gastrointestinal and colonic ischemic events).
Symptoms of gastrointestinal and colonic ischemic events include:
- sudden or severe stomach pain
- stomach pain after meals
- weight loss
- nausea or vomiting
- constipation or diarrhea
- bloody diarrhea
- problems with blood circulation to your legs and feet (peripheral vascular ischemia). Symptoms of peripheral vascular ischemia include:
- cramping and pain in your legs or hips
- feeling of heaviness or tightness in your leg muscles
- burning or aching pain in your feet or toes while resting
- numbness, tingling, or weakness in your legs
- cold feeling or color changes in 1 or both legs or feet
- hives (itchy bumps); swelling of your tongue, mouth, or throat
- medication overuse headaches. Some people who use too many IMITREX injections may have worse headaches (medication overuse headache). If your headaches get worse, your healthcare provider may decide to stop your treatment with IMITREX.
- serotonin syndrome. Serotonin syndrome is a rare but serious problem that can happen in people using IMITREX, especially if IMITREX is used with anti-depressant medicines called SSRIs or SNRIs.
Call your healthcare provider right away if you have any of the following symptoms of serotonin syndrome:
- mental changes such as seeing things that are not there (hallucinations), agitation, or coma
- fast heartbeat
- changes in blood pressure
- high body temperature
- tight muscles
- trouble walking
- seizures. Seizures have happened in people taking IMITREX who have never had seizures before. Talk with your healthcare provider about your chance of having seizures while you take IMITREX.
The most common side effects of IMITREX Injection include:
- pain or redness at your injection site
- tingling or numbness in your fingers or toes
- warm, hot, burning feeling to your face (flushing)
- discomfort or stiffness in your neck
- feeling weak, drowsy, or tired
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of IMITREX. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store IMITREX Injection?
- Store IMITREX between 36°F to 86°F (2°C to 30°C).
- Store your medicine away from light.
- Keep your medicine in the packaging or carrying case provided with it.
Keep IMITREX and all medicines out of the reach of children.
General information about the safe and effective use of IMITREX
Medicines are sometimes prescribed for purposes other than those listed in Patient Information leaflets. Do not use IMITREX for a condition for which it was not prescribed. Do not give IMITREX to other people, even if they have the same symptoms you have. It may harm them.
This Patient Information leaflet summarizes the most important information about IMITREX. If you would like more information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about IMITREX that is written for healthcare professionals.
For more information, go to http://www.gsk.com or call 1-888-825-5249.
What are the ingredients in IMITREX Injection?
Active ingredient: sumatriptan succinate
Inactive ingredients: sodium chloride, water for injection
This Patient Information and Instructions for Use has been approved by the U.S. Food and Drug Administration.
Patient Instructions for Use
IMITREX STAT dose System
Read this Patient Instructions for Use before you start to use the IMITREX STATdose System. There may be new information. This information does not take the place of talking with your healthcare provider about your medical condition or treatment. You and your healthcare provider should talk about IMITREX Injection when you start taking it and at regular checkups.
Keep the IMITREX STATdose System out of the reach of children.
Before you use the IMITREX STATdose System
When you first open the IMITREX STATdose System box, the Cartridge Pack and the IMITREX STATdose Pen® are already in the Carrying Case for your convenience.
The grey and blue Carrying Case is used for storing the unloaded Pen and the Cartridge Pack when they are not being used.
The Cartridge Pack holds 2 individually sealed Syringe Cartridges. Each Syringe Cartridge holds 1 dose of IMITREX® (sumatriptan succinate) Injection. The Cartridge Pack for the 4-mg strength of this medicine is yellow, and the Cartridge Pack for the 6-mg strength is blue (as shown). Refill Cartridge Packs are available.
Dr. David Wilson can pursue a medical malpractice lawsuit against the hospital where his daughter, Dr. Sandra Wilson, was on staff and received treatment prior to her death in 2006, reports the Yakima Herald-Republic. Individuals in need of financial assistance to pursue medical malpractice lawsuits can often secure legal loans.
The lawsuit alleges doctors at Sunnyside Community Hospital improperly administered a migraine medication, Imitrex, to 35-year-old Sandra Wilson, who sought treatment for symptoms including nausea and speech problems, the Herald-Republic reports. The news source says Wilson began having seizures after being on the medication for three days. She died after being transferred to a Spokane hospital, where it was discovered the Imitrex had exacerbated a preexisting constriction of one of her major brain arteries.
According to the Herald-Republic, a previous ruling in the case found David Wilson could not sue Sunnyside in part because his daughter had been a contracted physician there. An appeals court recently reversed this dismissal, meaning the case will go to trial if a settlement is not reached.
Before the tablet version of Imitrex went on the market in 1995, Mother Jones reported on Dianne Riley, a 41-year-old mother of four who died from a heart attack that seemed to be the result of an adverse reaction to the drug.
Watching this video, I felt appalled by this misuse and abuse of my values. I felt outraged, as a physician, at the utter contempt with which GlaxoSmithKline holds the medical profession. I felt frightened for all of us who consume the products of these corporations.
(Dr Peter Breggin 2012 Huffington Post)
“Four pharmaceutical executives stand with their backs to a darkened Las Vegas auditorium. Smoke machine fog billows at their heels while a platform slowly rotates them to face thousands in the audience. A song from the Space Jam soundtrack plays, stage lights brighten, and suddenly a giant model pill dispenser is revealed on stage. Cue sparklers.
Y’all ready for this?
This is not a parody of corporate conduct. It’s Exhibit 28A, a video (above) uploaded by the Department of Justice last week from court documents pertaining to the “largest health care fraud settlement in U.S. history.”
The scene itself is from the real and not-so-distant past, at GlaxoSmithKline’s 2001 sales launch for its asthma medication Advair, which the company promoted as first-line therapy for mild asthma patients. The study that conclusion came from, however, had been flatly rejected by the FDA, and later received a black box warning as the result of deaths in halted clinical trials.
The US complaint alleged that GSK continued to market the product as such anyway—as recently as 2010—while providing kickbacks for high-prescribing physicians to boot.2010—while providing kickbacks for high-prescribing physicians to boot.”
Following on from my recent blog post about GSK Whistle-blower Greg Thorpe’s legal complaint (which eventually led to a ‘slap on the wrist’ 3 Billion dollar fine for GSK in 2012), I’d like to delve a little deeper into why this complaint was so important. There were a number of drugs in the complaint which GSK marketed illegally off-label, but because Paxil (Seroxat) was the drug which I was prescribed, I intend to focus on the Seroxat (Paxil) part. The post about Greg Thorpe I did 2 days ago, has had a couple of hundred views already, and I know Glaxo are reading these posts (I can see who views), so I’d like to also say to the GSK spies- how can you continue to work for such an abhorrent company? a company that kills kids for profit…
“…Some estimate that more than 50,000 under-18s in the UK were prescribed Seroxat between 1990, when it was licensed here, and last year when the ban was imposed by Government medical regulators…”
“..Anguished parents have complained that their children became suicidal while on Seroxat then showed horrendous withdrawal symptoms when they tried to come off it…”
As you can see from the exhibit video above, the corporate culture at GSK is all about sales and profits, and as we now know from Greg’s complaint- at GSK- ethics, morals and patients lives -were completely disregarded- for the pursuit of profits. Despite GSK’s claims to the contrary, it is unlikely that GSK’s corporate culture has changed much. They were found guilty of a massive bribery scam in China just last year, and they are currently weathering accusations of similar bribery scams globally. They refuse to engage with those in the UK who were prescribed Seroxat in Europe, despite having paid out millions to damaged consumers in the US.
They continue to deceive their consumers, and patients continue to be damaged from dodgy GSK drugs. Seroxat is just one example.
Has their culture changed much? I don’t think so.
Is Andrew Witty any different to his predecessor JP Garnier?
Not a lot.
Perhaps Andrew Witty is slightly different, in that he comes across as more sincere, humble, and open to change.
However, personally I don’t believe that Witty is any different ethically to JP, he’s just more convincing and less arrogant, and in comparison to JP he seems much more likable, but I think that’s why they chose him- he’s the ‘acceptable face of Big Pharma’ (or not, as the case may be).
If Andrew Witty was serious about changing GSK’s ethics, why has he consistently ignored pleas to meet with Seroxat campaigners over the years?
Seroxat killed kids, and adults too. It continues to kill, and will continue to, until it is taken off the market. Andrew Witty knows this, yet Andrew witty has not uttered one word about Seroxat in public. I just don’t understand how he sleeps at night.
“…The Seroxat User Group, back in 2011, asked for a meeting with GSK’s Andrew Witty. The meeting was an attempt to ask Witty for help on behalf of the thousands of patients suffering severe withdrawal problems at the hands of his company’s antidepressant Seroxat (known as Paxil in the US)
Witty declined, even though Janice Simmons, who operates the Seroxat User Group, had amassed over 60,000 emails from Seroxat patients, most of them are struggling to get off Seroxat…”
How can he claim to be an ethical CEO when he continues to ignore the damage that Seroxat is doing (globally) to people’s lives?
Witty talks the talk, but he certainly doesn’t walk the walk.
His statement at the time was: “
“Whilst these originate in a different era for the company, they cannot and will not be ignored,” he said in the statement. “On behalf of GSK, I want to express our regret and reiterate that we have learned from the mistakes that were made.”
Even here, when given the opportunity to apologize for decades of criminal misconduct, Witty chooses to continue to deceive the public and patients alike through his insincere statement. These charges didn’t happen in another era at all. Witty tried to spin it that way to make it seem that so, but this was a lie, and furthermore Witty worked for GSK at a very high level in this ‘era’ therefore he is also implicated in these shenanigans. Calling it another era is clever spin but it doesn’t take the heat away from his own possible involvement, particularly with the drug Wellbutrin/Zyban. Wellbutrin was named in the legal complaint against GSK in the department of justice fine, and Witty, it seems, was involved in Wellbutrin marketing at the time of these allegations, therefore it would suggest that he perhaps knows much more about it than he will ever admit. Of course, he is well protected by lawyers, money, and political connections too, so we won’t see him doing any jail time any time soon, but that doesn’t mean we can’t continue to document GSK’s appalling behavior, and Witty’s part in it all also.
At the end of the day, with Paxil/Seroxat- kids completed suicides, or attempted suicide, and self harmed, because they were prescribed a drug- that they should not have been. GSK illegally marketed Seroxat to kids despite being aware that it was dangerous. How can Andrew Witty reconcile his conscience about this? (that’s if he has one- some claim that CEO’s in these types of organizations are sociopaths therefore they likely don’t have a conscience). It is arguable whether Seroxat should be prescribed to anyone at any age, personally I believe it should be banned.
Of course, Seroxat is dangerous for adults to take too, it is a highly toxic drug, and has caused immeasurable harm. If Witty knows this, but he ignores it then is he also complicit in the deaths and damage to patients and consumers of Seroxat?
Does he have blood on his hands? if the buck stops with the CEO then it stops with Sir Andrew Witty, and surely then the Seroxat Scandal also lands at his door? Does then too, the responsibility for those harmed (children, babies, and adults alike) damaged and killed from Seroxat fall squarely on his shoulders? Who is responsible for the devastation from this abhorrent drug? GSK? Andrew Witty? The MHRA? The FDA? All of them?
I wonder would GSK executives and their lawyers push drugs like Seroxat or Wellbutrin on their own kids if they were depressed, down, or suffering from anxiety over exams, or a teenage break up? Would they give them Seroxat or Wellbutrin? maybe they would…maybe not… but would they warn them of the full side effect profile? and the full dangers?
Because only GSK has access to that information.
Dr David Healy, of the University of North Wales, said: “If the data had been out there from the start, we could have avoided some of the problems we have seen with Seroxat.
“If people had been aware of the evidence from the trials and seen the risks, they could have reduced the risks of adverse events happening. Parents could have been told to keep a closer eye on their children.
Below are excerpts from Greg Thorpe’s Paxil Complaint to the department of Justice. It cannot be underestimated the importance of Greg’s actions. He has undoubtedly saved lives. The fact that GSK knew Paxil (Seroxat) would harm kids, but continued to push it for childhood psychiatric disorders anyhow- should be deeply disturbing and concerning to the whole medical community, and for patients too.
It is now well established that Seroxat is a dangerous drug, but that is too late for Sara Carlin, Sharise Gatchell, Jamie Hoole and the many other Seroxat casualties. When is Mr Witty going to apologize for these deaths, and the destruction and damage to many thousands of families, loved ones and Seroxat survivors?
Dr David Healy (and others) intend to re-examine GSK’s controversial Paxil study 329 and their submission to the BMJ is expected to be revealed soon on this website:
“..When you look at the detail and accuracy of Greg Thorpe‘s written complaints distributed to the highest levels of Glaxo (See ‘Document Links’ Below) it’s almost surreal that the company took no corrective action. Now more than a decade later, GSK is essentially admitting that Thorpe had been right in 2001″.. Kenney said
“…As a Colorado Springs sales representative for GlaxoSmithKline, Greg Thorpe tried to put a stop to the practice. His manager wrote him up for not being a “team player” after he objected to the free spa treatments and pedicures, hunting trips, tickets to sports games and skiing junkets that his supervisors expected him to give out to doctors and others..”
“The sky was the limit,” said Thorpe, whose whistle-blower lawsuit against his former employer ended with a $3 billion settlement with the federal government. “Those who spent more money got rewarded because they were positioning the company for more business. And it did pay off.”
When GSK were fined 3 Billion dollars by the US department of Justice in 2012 (for various criminal/fraudulent activities spanning over more than a decade- which resulted in some cases- in deaths of patients/consumers) the media concentrated mainly on the headline grabbing “3 Billion dollar fine” and very little of the exhibits (and the content of the actual legal complaint) were highlighted. This is understandable, considering this was the biggest health care fine in US history, but the fine itself is only a very small part of the overall story. These exhibits reveal a sinister and sociopathic corporate culture at GSK; a culture which indicate (and considering GSK’s recent China bribe scandal– arguably- still display) an utterly callous disregard for patient health, and an insatiable appetite for fraud and corruption in the pursuit of profits.
The main whistle-blower behind this record breaking fine was a previous employee of GSK- Greg Thorpe. Greg spent 23 years with the company, but when they expected him to get involved in prescribing medications such as the anti-depressant Wellbutrin to kids, Greg felt the need to speak out. Typically, GSK responded by vilifying Greg, and making his life hell. Greg’s original mails (to the GSK upper management -about his absolute unwillingness to participate in these nefarious activities) make for sobering reading. I applaud Greg for his actions, he deserves much praise and respect for doing the right thing. He is a hero (in the true meaning of the word), and he is truly brave and courageous; however I wish I could say the same for the media coverage of the fine itself. Very little of these exhibits were printed online or in broadsheets. The coverage of the finer details was paltry. I always wondered though, why did the department of Justice not go back further than 2000 with the Wellbutrin (off label allegations)? It couldn’t be anything to do with the fact that Andrew Witty was head of marketing around 1997/98 and involved in promoting Wellbutrin also could it? surely not…
Aside from that, I was also disappointed to see that there was very little in this legal complaint about Paxil (Seroxat). However, I have since learned (from my source) that this part of the complaint should have been much longer. Again, I wonder why it was cut short? Another aspect of all this that is interesting is- the fact that there were other whistle-blowers: what was their contribution? What did they know about Paxil (Seroxat) withdrawal/suicides/birth defects etc, or other GSK crimes, where are their complaints and exhibits? Why do we see mostly stuff from Greg in the complaint? (with some input from Blair Hamrick), what did the other whistle-blowers reveal? (if anything at all?) Why do the other four whistle-blowers not speak out at all?
If either whistle-blowers Michael Lafauci, Lois Graydon, Thomas Geraghty, or Matthew Burke are reading this and they would like to contact me about anything in this post, please e-mail : firstname.lastname@example.org.
Furthermore, it seems to me that this 3 Billion dollar fine was merely a gift to GSK from Eric Holder, he did say, after all- that some companies were ‘too big to fall’ (he later countered this with a remark that ‘there is no such thing as too big to jail’ but it seems in Glaxo’s case, this wasn’t to be). GSK provide massive employment, investment, research to US states as well as donations to US institutions, academia etc, therefore perhaps Holder was correct, shoot down the beast, and the greater good is affected- however does this make it ethically sound to slap them on the wrist for corporate manslaughter of children? Or how about the birth defects from Paxil? what amount of fines can atone that crime?
The full 7th amended complaint can be found here
Personally, I believe, these several hundred pages of exhibits were the tip of the iceberg, who knows how much more could have been unearthed?
There were thousands of reps with access to these kinds of documents, and thousands more in the company would have been aware, to some degree..
If any of them have a conscience, and are reading this, contact me (anonymously if you like) on: email@example.com
The following are examples of exhibits (from Greg’s Complaint) detailing how GSK marketed their various products off-label illegally to doctors in the US.
Glaxo’s settlement agreement and the government’s charges against Glaxo
The settlement agreement signed by GlaxoSmithKline, the federal government and the whistleblowers describes not only the terms of the settlement of the whistleblower cases but also the whistleblower claims the government supported based on its investigation.
The claims the government stated in the settlement agreement describing Glaxo’s off-label marketing of Wellbutrin, Advair, Lamictal, Zofran, Imitrex and Valtrex and the financial inducements Glaxo gave to doctors to convince them to prescribe those drugs were based largely on the qui tam lawsuit brought by Phillips & Cohen’s whistleblower clients.
For more information about the government’s claims and the settlement amount allocated to each drug, see the Glaxo settlement agreement for the whistleblower cases and the Justice Department fact sheet about Glaxo’s $3 billion settlement.
Below are the claims the government made in the settlement agreement about Glaxo’s off-label marketing of Wellbutrin, Advair, Lamictal, Zofran, Imitrex and Valtrex and financial inducements offered to doctors to prescribe those drugs. The settlement agreement also contains allegations involving Paxil, which were based on a separate whistleblower lawsuit.
- Wellbutrin: During the period January 1, 1999 through December 31, 2003, GSK knowingly: (a) promoted the sale and use of Wellbutrin for conditions (including weight loss, the treatment of obesity, sexual dysfunction and in combination with other antidepressants) and at dosages other than those for which its use was approved as safe and effective by the FDA, and some of which were not medically-accepted indications as defined by 42 U.S.C. §1396r-8(k)(6) for which the United States and state Medicaid programs provided coverage for Wellbutrin; (b) made and/or disseminated unsubstantiated and/or false and/or misleading representations or statements about the safety and efficacy of Wellbutrin; and (c) offered and paid illegal remuneration to healthcare professionals to induce them to promote and prescribe Wellbutrin, in violation of the Federal Anti-Kickback Statute, 42 U.S.C. ‘ 1320a-7b(b). As a result of the foregoing conduct, GSK knowingly caused false or fraudulent claims for Wellbutrin to be submitted to, or caused purchases by Medicaid and the other Federal Health Care Programs.
- Advair: During the period January 1, 2001 through June 30, 2010, GSK knowingly: (a) promoted the sale and use of Advair for conditions and dosing regimens other than those for which its use was approved as safe and effective by the FDA (including first line use for mild or all asthma, and for asthma previously treated by short-acting inhalers alone), and some of which were not medically-accepted indications as defined by 42 U.S.C. § 1396r-8(k)(6) for which the United States and state Medicaid programs provided coverage for Advair (b) made and/or disseminated unsubstantiated and/or false and/or misleading representations or statements about the safety and efficacy of Advair (including that Advair was superior to the single component, inhaled corticosteroid alone, for patients previously treated by short-acting inhalers alone); and (c) offered and paid illegal remuneration to health care professionals to induce them to promote and prescribe Advair, in violation of the Federal Anti-Kickback Statute, 42 U.S.C. § 1320-7b(b). As a result of the foregoing conduct, GSK knowingly caused false or fraudulent claims for Advair to be submitted to, or caused purchases by Medicaid, Medicare and the other Federal Health Care Programs.
- Lamictal: During the period January 1, 1999 through December 31, 2003, GSK knowingly (a) promoted the sale and use of Lamictal for a variety of conditions other than those for which its use was approved as safe and effective by the FDA (including bi-polar depression, neuropathic pain, and various other mental diseases), and some of which were not medically-accepted indications as defined by 42 U.S.C. § 1396r-8(k)(6) for which the United States and state Medicaid programs provided coverage for Lamictal; (b) made and/or disseminated unsubstantiated and/or false and/or misleading representations or statements about the safety and efficacy of Lamictal concerning the uses described in section (a) of this sub–paragraph; and (c) offered and paid illegal remuneration to health care professionals to induce them to promote and prescribe Lamictal, in violation of the Federal Anti-Kickback Statute, 42 U.S.C. §1320-7b(b). As a result of the foregoing conduct, GSK knowingly caused false or fraudulent claims for Lamictal to be submitted to, or caused purchases by Medicaid and the other Federal Health Care Programs.
- Zofran: During the period January 1, 2002 through December 31, 2004, GSK knowingly (a) promoted the sale and use of Zofran for a variety of conditions other than those for which its use was approved as safe and effective by the FDA (including hyperemesis or pregnancy-related nausea), and some of which were not medically-accepted indications as defined by 42 U.S.C. § 1396r-8(k)(6) for which the United States and state Medicaid programs provided coverage for Zofran; (b) made and/or disseminated unsubstantiated and/or false representations or statements about the safety and efficacy of Zofran concerning the uses described in section (a) of this sub-paragraph; and (c) offered and paid illegal remuneration to health care professionals to induce them to promote and prescribe Zofran, in violation of the Federal Anti-Kickback Statute, 42 U.S.C. § 1320-7b(b). As a result of the foregoing conduct, GSK knowingly caused false or fraudulent claims for Zofran to be submitted to, or caused purchases by Medicaid and the other Federal Health Care Programs.
- Imitrex, Lotronex, Flovent and Valtrex: From January 1999 through December 2004, GSK paid illegal remuneration for speaker programs, mentorships, preceptorships, journal clubs, advisory boards (including Local and Regional Advisory Boards and Special Issues Boards), Reprint Mastery Trainings, and provided gifts (including entertainment, cash, travel and meals) to health care professionals to induce them to promote and prescribe the drugs Imitrex, Lotronex, Flovent and Valtrex, in violation of the Federal Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b). As a result of the foregoing conduct, GSK caused false claims to be submitted to Medicaid and certain other Federal Healthcare Programs.
Why so little on Paxil (Seroxat)?
GlaxoSmithKline: former chairman denies knowledge of $3bn US deal
Richard Sykes says pharmacy firm’s issues ‘complicated’, as FairPensions urges pursuit of executive malpractice
Sir Richard Sykes, ex-chairman GlaxoSmithKline
Sir Richard Sykes, former chair of GlaxoSmithKline, which has been criticised for ‘putting profits above ethics’. Photograph: Richard Saker
Wednesday 4 July 2012 19.54 BST
Last modified on Wednesday 1 October 2014 12.41 BST
Sir Richard Sykes, the former chairman of GlaxoSmithKline, has refused to criticise actions at the large pharmaceutical company, saying he had “not a clue” about the details of a $3bn settlement with US authorities.
But critics said the case, involving issues dating to 1997, underlined the need for tougher action, which could include certain executives being jailed.
FairPensions, the campaign for responsible investment, linked the GSK scandal to the firestorm that has engulfed Barclays bank in the past week, and said the controversies were costing the City much more than tougher regulation ever could.
Sykes, now chairman of the Royal Institution, and the UK’s largest NHS healthcare trust, said the issues concerning the pharmaceutical group, where he had been chairman, were “complicated” and he was still digesting the case, despite a corporate statement from GSK more than 36 hours earlier.
“I have not had a chance to read the newspapers and have not a clue as to what is going on,” he said, from his home in London. “It is a complicated situation with two different companies [SmithKline Beecham and Glaxo Wellcome] and they did not really start coming together till 2001.”
Sykes was chief executive of Glaxo before the £100bn merger in 2000 but then stood down as chairman of the combined GSK in the middle of 2002.
A whistleblower, Greg Thorpe, first alerted the company to the entertainment offered doctors and the culture that allegedly put profits above ethics in 2001.
Sykes suggested that the problems could have related mainly to SmithKline, prior to its merger with Glaxo.
But GSK insisted that the problem was in the US and in the past: “Since Andrew Witty became chief executive in 2008, GSK has made significant changes at all levels within the company to ensure we act with integrity in everything we do, and these matters do not reflect the company that we are today.”
The company admitted in its settlement with various American authorities that it had been offering lavish holidays and hospitality to targeted doctors and encouraged the prescription of unsuitable anti-depressants to children.
GSK also paid for articles to appear in medical journals lauding its products, and hired “independent” doctors to promote the treatments.
Thorpe raised his concerns with David Stout, who was then head of the US business, and Bob Ingram, GSK’s chief operating officer. When he was forced out of the company he took his case to the regulators, who spent almost 10 years investigating the issues.
Stout became a non-executive director of another London-listed pharmaceutical company, Shire plc, and Ingram is chairman of the biotech firm Elan Corporation.
Louise Rouse, director of engagement at FairPensions, said shareholders should be asking searching questions to ensure there is sufficient oversight of people and practices at the new companies the executives had joined.
“Even though the management has moved on, shareholders at GSK need to ensure that the root and branch reform promised on paper has in fact been carried out,” she said.
Sidney Wolfe, director of the Health Research Group at the Washington-based campaign group Public Citizen, noted that the latest fine on GSK was just the latest in a series dating back to 1991.
He said: “Until more meaningful penalties and the prospect of jail time for company heads who are responsible for such activity become commonplace, companies will continue defrauding the government and putting patients lives in danger.”
So hot on the heals of more fraud by Merck [Merck Vaccine Fraud – 2nd US Court Case Over MMR Vaccine] we now have more fraud by GlaxoSmithKline. You can read the Associated Press breaking story here:
GlaxoSmithKline to pay $3 billion in fines, the largest health care fraud settlement in U.S. history – THE ASSOCIATED PRESS – Tuesday, July 3, 2012
The Justice Department said that British drugmaker will plead guilty to promoting popular antidepressants Paxil and Wellbutrin for unapproved uses. The company also will plead guilty to failing to report to the government for seven years some safety problems with diabetes drug Avandia, which was restricted in the U.S. and banned in Europe after it was found in 2007 to sharply increase the risks of heart attacks and congestive heart failure.
Instead of repeating the story we are going to set out the names of GSK’s Board and ask what they have done about this and also ask what is the next fraud to come out of the company? This is not the first time GSK has been mired in fraud. We list below the Board of Directors of GlaxoSmithKline today – so check out who was on the board, read the following facts and then ask yourself “should they still be on GSK’s Board?”
And don’t forget – what are we supposed to think of people like the GSK Board who hired James Murdoch of News International onto their Board of Directors to protect their reputation and then had to dump him because of all the corruption associated directly with James Murdoch at News Corporation and News International which is being examined publicly in the Leveson Inquiry.
And should British first ministers like Prime Minister David Cameron and Chancellor George Osborne cosy up to a company like GSK? Should we as the public cross the street to avoid GSK and all who have anything to do with it?
And let us be clear about the dates – PA report:
“The case against Glaxo was originally brought in January 2003 by two whistleblowers, former Glaxo sales representatives Greg Thorpe and Blair Hamrick. In January 2011, the federal government joined in the case.“
BUT PA also report:
“The company also will plead guilty to failing to report to the government for seven years some safety problems with diabetes drug Avandia, which was restricted in the U.S. and banned in Europe after it was found in 2007 to sharply increase the risks of heart attacks and congestive heart failure.“
If 2008 is the cut-off date then is it the case that any current GSK Director on the Board prior to 2008 is one of those ultimately responsible for overseeing fraud – yes that’s right – fraud?
We can also justifiably ask, is 2008 the appropriate cut-off date or should it be October 2010 when the European Medicines Agency withdrew the licence for Avandia? In other words the GSK Board of Directors as it was constituted up to and including October 2010 are all implicated as GSK was still marketing Avandia: European Medicines Agency experts have said Avandia, a leading diabetes drug, should be suspended from the market. BBC Health News 23 September 2010 Last updated at 17:13
As you can see of the 16 current GSK Board members, 10 were on the Board during and/or prior to 2008 and 11 up to October 2010. So should these people be on the Board of any company? And if not, what are they still doing there? These are fair questions to ask. After all, if they can let their companies get away with fraud then everyone might as well do the same. And what did they know of these frauds? And if they claim they knew nothing – then why are they on the Board of the Company in the first place.
PA reports: “Sir Andrew Witty, Glaxo’s CEO, expressed regret Monday and said the company has learned “from the mistakes that were made.”
It needs to learn more – like most of the Board of Directors should go and right now. Here they are:
Sir Christopher Gent – joined the Board as Deputy Chairman in June 2004.
Sir Andrew Witty – Chief Executive Officer – joined the Board in January 2008.
Professor Sir Roy Anderson – joined the Board in February 2007
Dr Stephanie Burns – Non-Executive Director – joined the Board in February 2007.
Stacey Cartwright – Non-Executive Director joined the Board in April 2011.
Larry Culp – Non-Executive Director joined the Board in July 2003.
Sir Crispin Davis – Non-Executive Director joined the Board in July 2003.
Simon Dingemans – Chief Financial Officer joined the Board in January 2011.
Lynn Elsenhans – Chief Financial Officer joined the Board in July 2012.
Judy Lewent – Non-Executive Director joined the Board in April 2011. BUT She is the former Executive Vice President and Chief Financial Officer of Merck & Co., Inc. which is a corporation which has previously been found guilty of fraud.
Sir Deryck Maughan – Non-Executive Director joined the Board in June 2004.
Dr Daniel Podolsky – Non-Executive Director joined the Board in July 2006.
Dr Moncef Slaoui – Chairman, Research & Development joined the Board in May 2006.
Tom de Swaan – Non-Executive Director joined the Board in January 2006.
Jing Ulrich – Non-Executive Director joined the Board in July 2012.
Sir Robert Wilson – Non-Executive Director joined the Board in November 2003
Yesterday I posted a public document which gave a judgement from a judge presiding over part of the GSK whistleblower complaint (which led to a record breaking 3 Billion dollar fine for GSK in 2012, after a US dept of Justice investigation). The complaint itself goes back decades, and in this particular part of the legal case, one of the ‘whistleblowers’, Blair Hamrick, was recently denied compensation for his claim for ‘unfair dismissal’. I have no idea how much exactly Blair expected to receive with this part of the claim, but I gather it would likely be in the “few million” bracket. However, I’m sure Blair probably isn’t feeling overly hard-done-by considering the multiples of millions he has already received from his original whistleblower case.
I found this document interesting because, although the 3 billion dollar fine itself made headline news back in 2012, little is known about the whistleblowers themselves. The only whistleblower who seems to have made much media appearances, since GSK were fined, is Blair Hamrick, and the (now failed) unfair dismissal case (which I posted yesterday) was brought against GSK by Blair Hamrick. The other whistleblower Greg Thorpe seems to have been the first to instigate the case against GSK, therefore it would seem that it was Greg who blew the whistle initially. Greg has given just one interview, and is apparently still caught up in legal actions but is beginning to speak out. However, apparently there were at least another 4 whistleblowers who were part of this case- Thomas Gerahty and Matthew Burke, were both mentioned in news articles but nothing has been forthcoming in the media from those two men. Why?
The two other apparent ‘whistleblowers’, have surnames Graydon, and LaFauci, and they apparently filed suit much later than the others. Why are these two men not mentioned in news articles? (but they are mentioned in court documents here). What did they reveal? or was it just a rehash of the previous claims already filed? Furthermore, what has the dubious Dr. Piacentile (who seems to have made his living through whistleblowing and suing drug companies who once courted him) got do do with some of the later claims?
Stone & Magnanini, a firm with a history of representing whistleblowers in groundbreaking settlements, represented Dr. Joseph Piacentile, a physician who was the first to blow the whistle on Johnson & Johnson and Janssen’s fraudulent conduct back in 2001. Following Dr. Piacentile’s filing, five other whistleblowers filed actions against the companies, and relators and their counsel formed a team to assist Government lawyers in achieving this groundbreaking settlement.
I have always thought that the GSK 3 Billion fine was a slap on the wrist for GSK, and I have also thought that paying out whistleblowers such high amounts of cash was bordering on obscene, particularly considering some of these drugs (detailed in the court complaint) killed people, and most of them caused a lot of harm. I understand that some of the whistleblower’s took risks, and should be rewarded for loss of earnings etc, but I don’t believe that all these whistleblowers were genuine whistleblowers. It would be interesting to ask them what drugs did they prescribe off-label themselves? (if any?). Why, and when did they decide to come forward, was it before or after they realized they would get rewarded handsomely? These are important questions.
There is no money that can replace the loss of your life from a drug like Seroxat (Paxil), or the loss of your health, and anyhow most people can’t get GSK anywhere near a court to claim compensation for that, particularly in the UK and Europe. In my opinion compensation from GSK is blood money, plain and simple- it is money tainted with bad karma, unless the person receiving it was a victim, or a real whistleblower (with genuine intentions not just freeloading on the back of a potential payout)- then I think the money is seriously tainted… Think of it this way- any money GSK has, and any money it pays out, has been earned on the back of fraud and corporate murder. It’s blood money– no doubt about it. It’s money soaked from the blood of Seroxat teenage suicides, Avandia heart attacks, babies with defects…
Another intriguing aspect of all this is, what happened to the Paxil complaint? Why did the main part of the original fine allegations focus on Advair? Why not Avandia or Paxil (Seroxat)? It seems to me that GSK got off extremely lightly for their most dangerous and damaging drugs- Paxil and Avandia- and that the department of Justice allowed the least damaging complaint (Advair) to gain the most traction and attention- particularly in the media. Why are the whistleblowers not talking about the whitewash and the deal that GSK did with the justice department? It was obviously a good deal for GSK- 3 months profits for decades of damaging and killing tens of thousands of people? why are they not talking about the nitty gritty of what GSK did- corporate manslaughter and corporate murder? Why did the big executives walk away scot free? What really happened in the dubious Lauren Stevens trial? What was Witty’s involvement (pre CEO) with Wellbutrin? (one of the main fraudulent drugs mentioned in the original DOJ complaint?).
If anyone has any information on any of this, please contact me on my e-mail
Money: Pink Floyd
Money, get away
Get a good job with more pay and you’re okay
Money, it’s a gas
Grab that cash with both hands and make a stash
New car, caviar, four star daydream
Think I’ll buy me a football team
Money, get back
I’m all right Jack keep your hands off of my stack
Money, it’s a hit
Don’t give me that do goody good bullshit
I’m in the high-fidelity first class traveling set
And I think I need a Lear jet
Money, it’s a crime
Share it fairly but don’t take a slice of my pie
Money, so they say
Is the root of all evil today
But if you ask for a raise it’s no surprise
That they’re giving none away
Away, away, way
Away, away, away